Gene Query: PMP22

Dataset Description Geneva Score
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 103.9
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 90.8
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 77.81
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 77.21
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 74.65
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors 73.32
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 68.99
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 59.5
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 58.64
RNA-seq analysis to identify the genes regulated by p53-SET interplay 57.63
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 57.61
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 56.01
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 56.01
Transcriptome of U251 cells overexpression complement component 7 54.61
RNA-seq of young and quiescent MRC-5 human fibroblasts 53.24
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 53.03
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 50.81
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 50.51
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 50.1
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 47.92
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 47.69
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 47.5
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 47.13
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 46.94
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 46.55
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 44.8
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 44.25
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 43.74
TGF-β promotes genomic instability after loss of RUNX3 42.46
PNET animal model: new insights (II) 41.53
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 41.3
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 36.75
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 36.53
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 35.99
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 35.99
Silencing p300 in MCF7 cells to study expression and alternative splicing 35.95
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 35.53
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 35.53
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 35.36
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 35.36
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 34.61
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 34.52
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 34.5
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 33.45
MCF-7 as a model for functional analysis of breast cancer risk variants 33.38
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 33.28
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 33.11
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 31.8
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 31.71
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 31.71
Hydrogel scaffolds promote neural gene expression and structural reorganization in human astrocyte cultures 31.66
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 30.81
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 30.77
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 30.77
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 30.36
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 30.29
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 30.28
Differential gene expression in Jagged1 treated human dental pulp cells. 30.08
Gene expression changes associated with resistance to tagraxofusp (SL-401) 29.69
Next Generation Sequencing Facilitates Quantitative Analysis of Retinoblastoma Transcriptomes 29.18
Identification of Nrf2 regulated genes by RNA sequencing 29.12
Nrf2 regulated genes in A549 cells 29.12
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 29.01
Expression profiling of etoposide-induced senescent cells 28.53
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 28.17
BI Human Reference Epigenome Mapping Project 28.05
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 27.98
R430: A potent inbibitor of DNA and RNA viruses 27.85
Expression level comparison under dividing and quiescent states in human primary fibroblasts 27.56
Nutritional control of protein translation 27.27
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 26.78
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 26.7
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 26.68
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 26.64
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 26.64
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 26.52
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 26.31
The Genomic Landscape of Atypical Fibroxanthoma 26.1
Effect of Hotair overexpression in human breast cancer cell lines 25.91
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 25.67
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 25.66
Brain organoids reproducibly generate the cellular diversity of the human cerebral cortex 25.5
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 25.23
IL-33 activates tumor stroma to promote intestinal polyposis 25.04
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 24.96
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 24.74
mRNA differential expression analysis in a human ex vivo model of chronic wounds 23.99
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 23.94
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 23.74
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 23.62
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 23.47
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 23.47
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 23.39
Lineage specific differentiation is influenced by state of human pluripotency 23.39
RNAseq of cell lines with knocked in ESR1 mutations 22.76
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 22.7
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 22.63
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 22.5
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 22.34
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 22.3
Differential expression of genes in AD169-infected MRC5. 22.26
Vitamin C dependent KDM6 demethylation specifies a functional chromatin state for endothelial-to-hematopoietic transition [RNA-Seq] 22.18
Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition 22.18
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 22.03
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 22.03
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 21.85
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 21.84
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 21.61
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 21.53
A global identification of PUM1 and PUM2 mRNA targets and their protein cofactors in human seminoma TCam-2 cells 21.03
High-efficiency RNA-based reprogramming of human primary fibroblasts 21.02
RNAseq Analysis in glioblastoma cells treated with Mepazine 20.74
MEIS1 regulates hematopoiesis in hPSCs 20.47
Statins modulate endothelial transcriptional profile by inhibiting EZH2 20.44
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 20.36
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 20.36
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 20.2
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 20.12
Gene expression changes upon drug withdrawal (Mel888 cell line) 20.12
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 20.04
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 20.04
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 19.91
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 19.81
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 19.73
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 19.73
Small RNA-seq of human granulosa cells reveals miRNAs in FSHR and aromatase genes 19.64
High-throughput RNA sequencing of human preovulatory cumulus and mural granulosa cells (mRNA) 19.64
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 19.61
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 19.61
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 19.54
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 19.46
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 19.46
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 19.28
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 19.19
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 19.04
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 19.0
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 18.96
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 18.94
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 18.69
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 18.19
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 18.08
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 17.99
SRSF2 mutations impair hematopoiesis and alter exon recognition 17.87
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 17.86
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 17.8
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 17.8
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 17.76
KLF6-dependent transcription in renal cancer cells 17.72
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 17.62
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 17.46
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 17.38
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 17.38
MicroRNA targetome analysis during HCMV infection 17.27
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 17.23
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 17.23
Generation and functional characterization of MDSC-like cells 17.14
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 17.06
The role of CFTR in islet function 17.02
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 16.95
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 16.95
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 16.93
RNA sequencing of BT142 and TS603 cell lines 16.93
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 16.88
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 16.76
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 16.71
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 16.69
Tumor exosome integrins determine organotropic metastasis 16.67
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 16.59
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 16.59
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 16.58
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 16.52
Effect of hypoxia and TGFβ1 on gene expression in HPF fibroblast cells 16.52
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 16.5
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 16.23
Ligand-dependent genomic function of glucocorticoid receptor in triple-negative breast cancer 16.23
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 16.2
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 16.11
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 16.11
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 16.02
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 16.02
Selective suppression of endothelial cytokine production by progesterone receptor 15.9
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 15.9
RNA-seq of shEZH2 cells 15.79
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 15.78
Gene expression profile in breast cancer cell lines using RNA sequencing 15.78
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 15.75
High-Throughput Kinetic Analysis of Fractional Killing 15.74
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 15.72
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 15.67
RNA-seq in HepG2 and IMR90 cells 15.64
Evolution of a transcriptional regulator from a transmembrane nucleoporin 15.64
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 15.62
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 15.62
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 15.61
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 15.48
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 15.42
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 15.29
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 15.27
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 15.27
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 15.22
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 15.05
Effect of mitochondria deficiency on senescence-associated gene expression 14.88
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 14.87
RNA-seq differential expression studies: more sequence, or more replication? 14.86
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 14.86
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 14.82
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 14.78
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 14.78
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 14.69
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 14.62
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 14.54
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 14.54
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 14.4
Differentially expressed vascular development genes for iPSC-ECs from CDI 14.37
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 14.23
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 14.09
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 14.05
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 14.04
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 14.04
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 14.01
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 13.93
Genome-wide analysis of the Integrator complex (HTS) 13.92
Genome-wide analysis of the Integrator complex 13.92
Cajal bodies are linked to genome conformation 13.86
Cajal bodies are linked to genome conformation [RNA-Seq] 13.86
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 13.8
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 13.78
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 13.77
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 13.77
Crizotinib v. DMSO in SW480 cells 13.75
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 13.74
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 13.7
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 13.7
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 13.62
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 13.6
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 13.58
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 13.58
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 13.58
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 13.57
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 13.5
The age and genomic integrity of neurons after cortical stroke in humans 13.4
RNA-seq analysis of uveal melanoma cells treated with FR900359 13.35
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 13.21
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 13.15
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 13.12
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 13.09
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 13.03
Regulation of hypoxia-inducible factor activity by ZMYND8 13.02
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 13.0
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 13.0
A practical evaluation of alignment algorithms for RNA variant calling analysis 12.99
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 12.92
RNA seq_A375 gSMARCB1 + A549 etoposide, Aurora kinases inhibitors treated 12.83
U2AF1 mutations alter splice site recognition in hematological malignancies 12.72
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 12.7
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 12.67
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 12.66
Analysis of the senescent transcriptome upon expression of a ZFP36L1 phosphomutant 12.66
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 12.61
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 12.59
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 12.59
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 12.58
METTL3 promotes translation in human cancer cells 12.55
hnRNP C is a key regulator of protein synthesis in mitosis 12.48
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 12.42
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 12.4
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 12.4
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 12.39
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 12.39
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 12.34
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 12.34
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 12.28
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 12.23
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 12.23
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 12.23
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 12.12
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 12.12
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 12.11
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 12.09
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 12.09
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 12.07
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 12.07
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 11.97
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 11.96
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 11.9
Toxoplasma gondii infection of human retinal pigment epithelial cells 11.88
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 11.87
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 11.87
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 11.84
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 11.84
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 11.83
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 11.74
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 11.6
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 11.51
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 11.48
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 11.47
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells 11.45
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells [RNA-seq] 11.45
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 11.4
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 11.36
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 11.33
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 11.33
Transcriptional effect of ETV1 knockdown in melanoma cells 11.13
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 11.1
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 11.08
Generation of trichogenic adipose-derived stem cells by expression of three factors 11.01
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 10.99
The chromatin modifier CHD8 targets autism risk genes during human neurodevelopment  10.91
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 10.79
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 10.77
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 10.74
In vitro modeling of human germ cell development using pluripotent stem cells 10.73
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 10.7
RNA Seq of HMVEC under hypoxia 10.7
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 10.68
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 10.65
KDM1A confers invasive and metastatic attributes in lung adenocarcinoma by modulating a non-canonical Integrin ß3-KRAS signaling pathway 10.64
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 10.45
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 10.37
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 10.26
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 10.22
Identification of differentially expressed genes between senescence and senescence bypass cells 10.11
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 9.99
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 9.91
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 9.9
Induced DNA demethylation, genome instability and transcription 9.88
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 9.88
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 9.87
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 9.87
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 9.85
Effect of drugs on transcriptomic profiles 9.82
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 9.71
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 9.68
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 9.44
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 9.44
Diarrhea in lymphocytic colitis: ERK1/2-dependent ENaC dysregulation and claudin-4-, -5- and -8-related barrier defects 9.41
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 9.31
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 9.29
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 9.29
ERBB3 and NGFR mark distinct skeletal muscle progenitor cells in human development enabling enrichment and maturation of hPSC muscle 9.27
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 9.14
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 9.14
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 9.05
Effects of rFVIIIFc on human macrophages 8.93
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 8.84
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 8.82
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 8.73
LINE-2 transposable elements are a source of functional human microRNAs and target sites 8.71
Expression profiling of converted and control dermal BJ fibroblasts 8.68
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 8.68
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 8.65
8.54
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 8.47
Metastasis in triple-negative breast cancer 8.46
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 8.46
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 8.44
Global epigenomic reconfiguration during mammalian brain development 8.33
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 8.29
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 8.28
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 8.28
RNA-Seq of LRRK2 G2019S Parkinson’s iPSC-derived astrocytes 8.18
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 8.16
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 8.13
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 7.99
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 7.99
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 7.98
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 7.67
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 7.62
Transcriptome of Stabilin-1 siRNA transfected human monocytes 7.58
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 7.33
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 7.28
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 7.21
ZIKV infection of monocytes activates inflammasome pathways 7.18
Impact on erythroid progenitor type on erythroid differntiation 7.06
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 7.05
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 6.89
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 6.83
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 6.83
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 6.78
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.75
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.75
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 6.7
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 6.68
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 6.68
FOXP2's impact on the primate transcriptome 6.68
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 6.63
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 6.6
Trans-differentiation of human adult peripheral blood T cells into neurons 6.47
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 6.46
RNA-seq transcriptonal profiling in human primary adult erythroid progenitor cells (ProEs) after shRNA-mediated depletion of TFAM and PHB2 expression 6.44
PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs 6.42
Select correlative genes involved in pathogenesis of idiopathic interstitial pneumonia by high-throughput sequencing analysis 6.41
Activity-dependent transcriptional changes in human neurons 6.31
m6A-dependent regulation of messenger RNA stability 6.23
RNA-seq of CD33 KO and control HSPCs 6.17
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 6.06
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 6.03
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 6.03
Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells 6.03
Disruption of GRIN2B impairs differentiation in human neurons 5.82
Single cell transcriptome of peritoneal cells 5.81
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.76
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.43
RNA-seq analysis upon ARID1B overexpression 5.42
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 5.41
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 5.41
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 5.39
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 5.23
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 5.12
SF3B1 Degron knockdown RNA-seq 5.02
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 5.01
Functional astrocytes differentiated from hiPSCs 5.01
nELAVL HITS-CLIP in Alzheimer's Disease patients 4.96
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 4.88
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 4.88
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 4.86
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 4.7
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 4.65
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 4.64
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 4.62
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 4.55
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 4.53
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 4.36
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 4.34
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 4.33
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 4.28
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 4.09
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 4.09
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 3.87
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 3.81
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 3.8
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.76
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.7
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 3.57
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 3.54
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 3.43
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 3.38
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 3.25
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 3.19
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 3.07
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 3.05
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.9
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.9
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 2.75
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 2.55
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.31
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.3
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.27
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 2.23
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 2.21
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 2.21
Transcriptomic analysis of human macrophages in 3D 2.13
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.04
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 1.88
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 1.88
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.81
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.81
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 1.76
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 1.65
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 1.65
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 1.65
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 1.63
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells 1.51
PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells (RNA-seq) 1.51
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 1.5
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.48
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 1.42
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.37
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 1.36
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.32
Modeling Human Cancer-induced Cachexia (Human) 1.23
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 1.18
TFAP2C signalling in human fibroblasts 1.16
Next Generation Sequencing Compares Effects of microRNA-9 perturbation in control and SZ hiPSC NPCs 1.15
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 1.14
BET bromodomain inhibition 1.14
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.05
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 0.78
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 0.76
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 0.7
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.69
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.68
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.58
RNA-Seq and expression data from human adipose tissue 0.58
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.58
Engineering Patient-Specific Tissue Implants 0.55
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.41
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.39
Aortic Valve Tissue: Stenosis vs. Sclerosis 0.36
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.31
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.29
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.24
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.21
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.2
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.2
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 0.19
Gene expression analysis of breast cancer cell-lines 0.09
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.09
hNSCs siRNA NOVA2 0.06
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation